We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A flyer to circulate to customers alongside a field safety notice covering what it is and why it's important to take action.
Patient factsheet to provide information on vaccines and vaccine safety.
Overview of the different types of MHRA safety communications about medicines, medical devices and other healthcare products, including what they are and who they are aimed at, and information on decision-making around safet…
Guidance on how to submit changes to labelling and patient information leaflets to MHRA.
Guidance on how to report suspected adverse incidents and safety concerns with diabetes management equipment to the Yellow Card scheme.
Guidance for marketing authorisation holders on drafting direct healthcare professional communications (DHPCs)
Guidance for manufacturers on reporting adverse incidents involving breast implants under the vigilance system.
Device-specific guidance for manufacturers on reporting adverse incidents under the vigilance system.
Dear colleague letter from Barry Cockcroft, Chief Dental Officer, dated 24 March 2011. Download :National Institute for Health and Clinical…
For manufacturers reporting adverse incidents with joint replacement implants under the vigilance system.
How to report adverse incidents involving insulin infusion pumps and integrated meter systems under the vigilance system.
For manufacturers reporting adverse incidents with intraocular lenses under the vigilance system.
Guidance for dispensing of valproate-containing medicines in the manufacturer’s original full pack, following amendments to the Human Medicines Regulations (HMRs).
How to report adverse incidents involving cardiac ablation devices under the vigilance system.
For manufacturers reporting adverse incidents with neurostimulators under the vigilance system.
The findings and recommendations of the Expert Advisory Group on paclitaxel drug-coated balloon catheters and drug-eluting stents which are used to treat patients with peripheral arterial disease.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).